Onera raises over €30M in Series C funding
Onera raises over €30M in Series C funding Onera Health, a leader in sleep diagnostic and monitoring solutions, closed a €30M Series C financing round.
Uncategorized
PolTREG receives US Patent Office Notice of Allowance for Treg cell therapy to treat Type-1 Diabetes
PolTREG S.A. announced it received a Notice of Allowance from the United States Patent and Trademark Office, covering the manufacturing of T-regulatory cells to treat Type-1 Diabetes, and ways the therapy is administered.
Halozyme Announces Roche Receives European Commission Approval of Tecentriq® SC with ENHANZE® Representing the EU’s First Subcutaneous PD-(L)1 Cancer Immunotherapy for Multiple Cancer Types
Halozyme Therapeutics, Inc. announced that Roche received European Commission marketing authorization of Tecentriq® SC co-formulated with ENHANZE®, Halozyme’s proprietary recombinant human hyaluronidase enzyme, rHuPH20.
InnoCare Announces Clearance of Clinical Trial of BCL2 Inhibitor ICP-248 by U.S. FDA
InnoCare Pharma, a commercial-stage biotech company, announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for the Company’s B-cell lymphoma-2 inhibitor, ICP-248.
InnoCare Announces Clearance of Clinical Trial of BCL2 Inhibitor ICP-248 by U.S. FDA Read More »
CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer
Menarini Silicon Biosystems, a pioneer of liquid biopsy and single-cell technologies, announced the recent publication of the STIC CTC trial data demonstrating the clinical utility of CTC count as an independent prognostic factor in advanced breast cancer.
Brain Navi Announces 100th Surgical Procedure Completed Using NaoTrac
Brain Navi announced the completion of the 100th case utilizing its neurosurgical navigation robot NaoTrac.
Brain Navi Announces 100th Surgical Procedure Completed Using NaoTrac Read More »
Opinion: Healthcare Nonprofits Drive Positive Change for Patients
No longer on the periphery of the life sciences market, nonprofit groups are bridging the gaps in drug discovery and development.
Opinion: Healthcare Nonprofits Drive Positive Change for Patients Read More »
FDA Action Alert: Satsuma, Theratechnologies and Heron
After a quiet start to 2024, the FDA is expected to decide on three applications over the next two weeks, including one for a nasal powder migraine treatment.
FDA Action Alert: Satsuma, Theratechnologies and Heron Read More »
Condiciones dolorosas comunes de pies y tobillos | Neuroma de Morton: una revisión práctica
Consiste en engrosamiento neuronal interdigital y fibrosis, se caracteriza por dolor ardiente en la planta del pie
Actualización: guía de la American Heart Association (AHA) | Soporte vital cardiovascular avanzado (ACLS)
Los aspectos destacados de las modificaciones para el servicio de Emergencias de las directrices de la American Heart Association